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Abstract A large number of diseases can mimic a vas-
culitis. The diagnosis can be challenging due to the simi-
larity with several diseases that have a different
pathogenesis. As reported in the literature, incontinentia
pigmenti (IP), a rare genetic disorder, can present vascular
alterations on eye, brain and lung. We report a case of
peripheral arterial disease in a patient with IP, suggesting
further vascular localizations of the disease.
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Incontinentia pigmenti (IP), or Bloch-Sulzberger syn-
drome, is a rare X-linked genetic disorder ascribed to the
NF-kB essential modulator (NEMO)/IkB kinase-c
(IKBKc) gene mutation. The NF-kB signaling pathway
regulates the expressions of genes that are involved in
many immune, inflammatory and apoptotic mechanisms
[1]. IP has a wide spectrum of clinical presentations. Skin
lesions classically evolve through four stages: a vescicol-
obollous, verrucous, hyperpigmented and finally, a hypo-
pigmented stage usually lasting a lifetime. Alopecia, nail,
breast, dental, ocular or central nervous system abnormal-
ities can also be observed. The diagnosis is principally
based on clinical criteria (Table 1) and molecular genetic
testing of NEMO mutation. In the majority of cases, IP is
caused by a large-scale deletion of NEMO exons 4–10
[2, 3].
Retinal and brain vascular abnormalities are well
described in the literature [4, 5]. We report a case of
peripheral arterial disease in a young patient with IP.
A 16-year-old female was referred to our centre because
of a suspected vasculitis. From her childhood she had
presented bilateral coldness and slight cyanosis of the
lower extremities. In the last years, however, cyanosis and
coldness progressively worsened, with the appearance of
severe pain of the toes. At the same time, skin ulcers
appeared on the first and fourth left toes (Fig. 1a, b).
A detailed analysis of the clinical history gave no evi-
dence of autoimmune diseases, vasculitis or coagulation
defects. Laboratory tests, such as full blood count, meta-
bolic panel, erythrocyte sedimentation rate (ESR) and
C-reactive protein (CRP) were within normal limits.
Antinuclear antibodies (ANA), anti-dsDNA, anti-extract-
able nuclear antigens (ENA), anti-neutrophil cytoplasm
antibodies (ANCA), anti-phospholipid antibodies (aPL)
and lupus anticoagulant (LAC) were absent. Repeated
evaluations of serum specimens, collected and separated
while warm, were negative for cryoglobulins, complement
fractions (C3, C4) and rheumatoid factor (RF). Other cold-
related diseases were also excluded by specific tests, such
as cold agglutinins or cryofibrinogen. Doppler ultrasound
(US) examination of the lower extremities gave findings
compatible with a complete bilateral occlusion of the
posterior tibial artery with a collateral circulation main-
taining a reduced blood flow below the occlusion. The US
also revealed a severe bilateral stenosis of the anterior
tibial artery. Complete US evaluation of the other arteries
and an echocardiogram were normal. The 18F-fluorode-
oxyglucose positron emission tomography (PET) did not
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document local metabolic activity nor gave evidence of
systemic underlying disease. Magnetic resonance angiog-
raphy (MRA) showed progressive narrowing of the tibial
artery and its apparent absence in the distal tract, but was
early interrupted because of an adverse reaction to the
contrast agent. The angiogram of the lower extremities,
however, confirmed the lack of blood flow to tibial arteries
(Fig. 1c, d).
The patient did not give the consent to undergo a skin
biopsy. She had no risk factors for vascular disease, but she
had a 1-pack year history, having started smoking at the
age of 14. Therefore, a Buerger’s disease was suspected.
The patient gave up smoking and started steroid therapy
but did not show any improvement. Due to the lack of
response and the absence of thrombotic and inflammatory
findings, other diagnostic hypotheses were evaluated. The
patient is the only child of non-consanguineous caucasian
parents and her mother was affected by IP. At birth, the
patient had presented an erythematous rash followed by
some vescicle eruptions with a linear pattern on forearms
and thigh, and IP had been suspected. At present, a com-
plete skin examination disclosed slight hypopigmented
areas of both legs and dystrophic changes in toenails. The
patient did not present dental or ocular abnormalities and
the brain magnetic resonance was negative. The deletion of
exons 4–10 within the NEMO gene was found, hence
confirming the diagnosis of IP.
Our findings support the potential relevance of vascular
pathology in IP, by demonstrating vascularization defects
of the lower extremities in a patient with IP. It was not
possible to obtain further evidence of such an association
through biopsy specimens or other diagnostic tools. Skin
biopsy was not taken, because the patient refused consent
but, keeping in mind the presence of the arterial obstruc-
tion, we did not expect local alterations of circulation or
skin. Repeated controls, however, seem to exclude other
potential diagnosis. Buerger’s disease was excluded based
on several clinical and instrumental findings. First,
Table 1 Diagnostic criteria for IP
Major criteria
Erythema followed by blisters/vesicles
Skin involvement stage I (first weeks of life to age four months)
Hyperpigmented streaks and whorls that respects
Blaschko’s lines
Skin involvement stage III (age four months to 16 years)
Pale, hairless, atrophic linear streaks or patches
Skin involvement stage IV (adolescence through adulthood)
Minor criteria
Hypodontia, anodontia, microdontia, and abnormally shaped teeth
Alopecia
Mild ridging or pitting of the nails, Onychogryphosis
Peripheral neovascularization of the retina
The diagnosis can be made if at least one of the major criteria is
present
Fig. 1 Ulcers of the left foot at
an early stage (a, b). Angiogram
of lower extremities showing
bilateral interruption of the
tibial arteries (c, d)
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coldness and cyanosis of the lower extremities have
appeared long before the patient started to smoke and she
was not heavy smoker. Second, instrumental findings
revealed major defects in the blood flow, without signs of
inflammation or thrombosis. Chilblain lupus was consid-
ered, but the presence of arterial obstructions did not fit
with such a diagnosis. A diagnosis of fibromuscolar dys-
plasia (FMD) was also considered. FMD, a degenerative
angiopathy of the medium-sized arteries, usually affects
young females and can virtually affect every arterial dis-
trict. A complete evaluation of the arterial tree, however,
did not reveal alterations of the arterial districts that are
most frequently involved in FMD, such as renal and carotid
ones. Although literature reports the involvement of
extremities in FMD, in our case angiographic findings did
not show the typical ‘‘string of beads’’ aspect and there was
no clinical or instrumental evidence suggesting FMD.
On the other hand, the importance of vasculopathy as a
pathogenetic mechanism in IP is supported by several
studies [6–8]. The majority of ocular changes observed in
IP can arise from retinal vascular abnormalities and the
central nervous system dysfunctions can be associated with
microangiopathic processes or arterial defects [9]. Finally,
three cases of pulmonary hypertension associated to vas-
cular lung abnormalities have been described to date [10].
NEMO gene mutation plays a critical role in anti-apoptotic
processes. NF-kB reduced activity was associated with a
wide spectrum of defects, involving many different organs.
As suggested by the literature data, through unknown
mechanisms, vasculopathy can be a significant feature of
the IP phenotype, potentially related to altered apoptotic
pathways. We can hypothesize an abnormal development
of the arterial wall with a functional component. The
abnormalities in vascular development observed in IP
patients on brain, eye and lung lead to ischemic attacks,
strokes, retinal detachment and arterial hypertension,
respectively. Although the pathogenetic mechanism is still
elusive, we can think that also the peripheral arteries can
present similar abnormalities in vascular development,
inducing a critical reduction in the blood flow. Such an
involvement, not yet reported in the literature, cannot be
demonstrated through specific tests to date and should be
confirmed by further observations. Our report, however,
could suggest the usefulness of carefully collecting the
medical history in young patients with suspected vasculitis,
considering IP as a possible cause of arterial obstruction.
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